ABOUT US
Making medical care more accurate and understandable with digital twins.
MEDICAL IP leads a paradigm shift in healthcare with innovative technologies.
Built on digital twin, AI and applied 3D technologies, we develop medical imaging analysis technologies that deliver solutions benefiting both patients and clinicians. MEDICAL IP is shaping a new future for healthcare with better medical experiences.
Core Values
LIFE
Technology that saves lives and helps with medical care is paramount.
INNOVATION
We continuously research and develop new and innovative technologies that the medical field and world want.
TRUST
We focus all of our abilities to develop accurate and precise technologies and products that medical staff and patients can trust.
EQUALITY
We welcome and respect all opinions. We value the mutual growth of customers and employees.
Partners & Recognition
7 consecutive years ‘Sample Vendor’
Inception Partner
‘1st Spin-off Start-up’Exclusively Partnered with
Vision
Empowering Medicine,Saving Lives
Mission
- Research technology that leads innovation
- Solve problems that arise in the medical field
- Develop medical solutions that save lives
History
Milestones since our founding as the first spin-off of Seoul National University Hospital.
7 milestones
- 10
- Biological age analysis software DeepCatch Bioage registered with the MFDS (Class I medical device)
- Participated in KoinXchange, co-hosted by the Ministry of Foreign Affairs, the Stop TB Partnership (STBP) and KOICA, to discuss global cooperation on tuberculosis and respiratory infectious diseases
- MEDIP Box adopted by more than 30 educational institutions in Korea, with repeat purchases from major universities, expanding digital twin-based anatomy education in the classroom
- 09
- Participated in the 2026 Concordia Annual Summit in New York, USA, presenting a global health strategy powered by medical imaging AI
- 06
- Joint study with Italian researchers using AI body composition analysis software DeepCatch identified an association between body composition and cancer-related mortality risk in colorectal cancer patients, published in La Radiologia Medica
- Invited to an AI business leaders' meeting hosted by NVIDIA CEO Jensen Huang
- 05
- AI body composition analysis software DeepCatch featured as a case of advanced body composition analysis technology in a review paper by Italian researchers in the Journal of Cachexia, Sarcopenia and Muscle (IF: 9.9)
Testimonials
In terms of developing innovative educational content, MEDICAL IP's products offered the most effective solution.
Hyung-Jin Choi, M.D., Ph.D.Seoul National University